Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
Clinical trial NCT07509112 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07509112
- Sponsor
- Kirby Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.